Clinical Trial Update: A Clinical Trial to Demonstrate the Efficacy of Cangrelor [Phase 3]

View source ↗

Summary

A Phase 3 trial of cangrelor for myocardial infarction and acute coronary syndromes was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Cangrelor (cangrelor)

Snippet

Sponsor: The Medicines Company | Conditions: Myocardial Infarction (MI), Acute Coronary Syndromes (ACS) | Phase 3 | Status: TERMINATED | Results posted: 2014-04-23